David, H N
Dhilly, M
Degoulet, M
Poisnel, G
Meckler, C
Vallée, N
Blatteau, J-É
Risso, J-J
Lemaire, M
Debruyne, D
Abraini, J H
Article History
Received: 29 September 2014
Revised: 6 January 2015
Accepted: 20 January 2015
First Online: 7 July 2015
Competing interests
: HND was a paid scientist at NNOXe Pharmaceuticals, QC, Canada. ML is a medical director at Air Liquide, Paris, France. Both companies, NNOXe Pharmaceuticals (NNX) and Air Liquide (AL), have patents on the use of argon as a medical gas (granted: FR2956323 (AL); pending: FR2996457 (AL), FR3004312 (AL), FR3004350 (AL), GB1310588.7 (NNX)). The remaining authors declare no conflict of interest.